Yeah the so-called "Downrampers" often overlook the deal between CAN and CSIRO, which is to do clinical research, who of course would lead to TGA product approval. Paying in a bit of scrip is fantastic for a business like CAN who is preserving cash.
CAN Price at posting:
69.5¢ Sentiment: None Disclosure: Held
